久久一区二区三区四区_欧美高清dvd_日韩欧美在线看_国产精品欧美一区二区_av天天看_欧美精品免费观看二区

 華仁藥業(yè), Huaren Pharmaceutical 
 華仁藥業(yè)股份有限公司（簡(jiǎn)稱華仁藥業(yè)）成立于1998年5月，2001年8月完成股份制改造，是專業(yè)生產(chǎn)非PVC軟袋輸液的高新技術(shù)企業(yè)。公司是由華仁世紀(jì)集團(tuán)控股，紅塔創(chuàng)新投資控股有限公司、廣發(fā)信德投資股份有限公司、中國(guó)藥科大學(xué)等國(guó)內(nèi)知名企業(yè)、院校參股的集產(chǎn)、學(xué)、研一體的新型股份公司。公司注冊(cè)資本2.183635億元，總資產(chǎn)12.4748億元，公司擁有普通型輸液、治療型輸液、營(yíng)養(yǎng)型輸液三大類產(chǎn)品，共有二十七個(gè)品種、六十七個(gè)規(guī)格的產(chǎn)品成功上市。2010年8月25日，公司在深圳證券交易所創(chuàng)業(yè)板正式掛牌上市，首次公開發(fā)行股票5360萬(wàn)股，股票簡(jiǎn)稱“華仁藥業(yè)”，股票代碼為“300110”。

公司位于青島市高科技工業(yè)園西北側(cè)，毗鄰海爾工業(yè)園、惠特工業(yè)園和嶗山風(fēng)景度假區(qū)，風(fēng)景秀麗，空氣清新，水源來(lái)自嶗山地下水，水質(zhì)優(yōu)良，符合制藥廠的環(huán)境及水源要求。公司占地面積5.9萬(wàn)平方米，一期工程建筑面積1.36萬(wàn)平方米，二期工程建筑面積2.08萬(wàn)平方米。廠區(qū)布局合理，綠化優(yōu)良。

公司一期工程是由國(guó)際著名醫(yī)藥工程建設(shè)公司意大利STERIL公司設(shè)計(jì)、安裝、調(diào)試并實(shí)施“交鑰匙工程”。1998年公司從歐洲引進(jìn)了世界最先進(jìn)的制水、配液、制袋灌封、滅菌等核心生產(chǎn)設(shè)備，保證了產(chǎn)品品質(zhì)的領(lǐng)先優(yōu)勢(shì)；雙室袋生產(chǎn)線的引進(jìn)，更是填補(bǔ)了國(guó)內(nèi)空白。

隨著市場(chǎng)的不斷增長(zhǎng)，華仁藥業(yè)二期工程于2008年4月5日開工，并于2009年8月27日整體通過(guò)國(guó)家GMP認(rèn)證；該工程擁有國(guó)內(nèi)同行業(yè)最先進(jìn)的自動(dòng)化生產(chǎn)線，以及一個(gè)全自動(dòng)的現(xiàn)代化立體倉(cāng)庫(kù)，它的投產(chǎn)成功是華仁藥業(yè)發(fā)展史上的又一個(gè)里程碑；二期工程的建成使我們不但擁有了近億的產(chǎn)能，更增強(qiáng)了我們的產(chǎn)品在質(zhì)量和成本上的市場(chǎng)競(jìng)爭(zhēng)力。

醫(yī)藥行業(yè)是關(guān)系國(guó)計(jì)民生的大行業(yè)，是一個(gè)決不允許出現(xiàn)劣質(zhì)不安全產(chǎn)品的行業(yè)；正是本著這樣一種對(duì)生命健康負(fù)責(zé)的態(tài)度，公司秉持“健康從點(diǎn)滴做起”的企業(yè)精神，實(shí)施全員、全方位、全過(guò)程的質(zhì)量管理；堅(jiān)持“健康、環(huán)保、安全”的生產(chǎn)理念，嚴(yán)格按照國(guó)家GMP標(biāo)準(zhǔn)及SFDA要求，對(duì)人員、設(shè)備、儀器、工藝方法、環(huán)境等進(jìn)行全方位的驗(yàn)證、管理和控制，并從原料、中間品到成品全過(guò)程進(jìn)行物理、化學(xué)、生物學(xué)的檢測(cè)、管理和控制，達(dá)到美國(guó)FDA、歐洲藥典標(biāo)準(zhǔn)和國(guó)家標(biāo)準(zhǔn)，處于國(guó)內(nèi)領(lǐng)先水平。

在研發(fā)方面，公司新擴(kuò)建的研發(fā)中心研發(fā)的附加值極高、市場(chǎng)適用性與競(jìng)爭(zhēng)力較強(qiáng)的腹膜透析液、脂肪乳、氨基酸、代血漿、腸外營(yíng)養(yǎng)雙室袋等非PVC軟包裝輸液項(xiàng)目也取得了可喜的進(jìn)展與突破。

公司還堅(jiān)持管理創(chuàng)新、技術(shù)創(chuàng)新、服務(wù)創(chuàng)新，積極推進(jìn)和實(shí)施ERP系統(tǒng)的建設(shè)，以優(yōu)化工作流程，提高工作效率。憑借著卓越的產(chǎn)品質(zhì)量和完善的售后服務(wù)，公司產(chǎn)品被客戶廣泛接受和認(rèn)可，產(chǎn)品成功進(jìn)入北京、上海、廣東、南京、浙江、湖北、山東、東北三省等全國(guó)26個(gè)省市；全國(guó)已建立了12個(gè)銷售中心，在全國(guó)非PVC軟袋輸液市場(chǎng)占有率居前三甲。

經(jīng)過(guò)十余年的發(fā)展，公司先后取得了“國(guó)家重點(diǎn)技術(shù)改造‘雙高一優(yōu)’項(xiàng)目”、“全國(guó)AAA級(jí)信譽(yù)企業(yè)”、“山東省質(zhì)量管理獎(jiǎng)”、“山東省著名商標(biāo)”、“山東省守合同重信用企業(yè)”、“2008青島市最具有成長(zhǎng)型中小企業(yè)”、“青島市改革開放三十年風(fēng)云企業(yè)”、“建國(guó)六十周年山東省醫(yī)藥行業(yè)卓越企業(yè)”、“2009年消防安全工作先進(jìn)單位”、“2009年度紅十字博愛銀獎(jiǎng)”、“2009年度中國(guó)誠(chéng)信企業(yè)”、“2010年度紅十字博愛銀獎(jiǎng)”、“2011年度消防工作先進(jìn)單位”、第三屆中國(guó)優(yōu)秀醫(yī)院服務(wù)商品牌“金如意獎(jiǎng)”、“中國(guó)馳名商標(biāo)”等一系列榮譽(yù)，被福布斯評(píng)為“2009福布斯最具潛力中小企業(yè)”，并成為中國(guó)人民解放軍總后勤部、衛(wèi)生部應(yīng)急儲(chǔ)備的定點(diǎn)輸液生產(chǎn)企業(yè)。

作為專業(yè)生產(chǎn)非PVC軟袋輸液的高新技術(shù)企業(yè)，華仁藥業(yè)以改善人類“后健康”為己任，秉承“輸液質(zhì)量肩負(fù)生命之托，責(zé)任重于泰山”的企業(yè)理念，用安全、優(yōu)質(zhì)的輸液產(chǎn)品和完善的客戶服務(wù)回報(bào)社會(huì)，致力于打造國(guó)內(nèi)一流的非PVC輸液生產(chǎn)基地。

Qingdao Huaren Pharmaceutical Corp.(briefly as Huaren) was founded in May of 1998 and finished its shareholding reform in August of 2001. It is a new high-tech enterprise which is a professional manufacturer of Non-PVC I.V. solution. It is one modern-style joint-stock company covering the production, marketing and R&D of I.V. Solution. The holding company is Qingdao Huaren Group Ltd., enterprises such as HongTa Innovation Investment Co., Ltd., Guangfa Xinde investment Co., LTD and China Pharmaceutical University etc. take the share of Huaren. The company has registered capital of 160 million yuan and permanent assets of 600 million yuan. There are three kinds of injection, conventional injection, therapeutic injection, nutritious injection, with products of 27 kinds and 57 specifications in the market.
The company is located in the northwest of Qingdao High-Tech Industrial Park, adjoins to Haier Industrial Park, Whitt Industrial Garden and Mt. Laoshan scenic spot, with beautiful scenery, fresh air and groundwater resources from Mt. Laoshan which conforms to pharmaceutical manufacturing environment and water resource requirement. The company covers an area of 59,000 square meters, the first stage construction covers an area of 13,600 square meters, and 20,800 square meters for second stage construction. The layout is reasonable and the afforestation is fine.
The first stage construction was totally designed and constructed by STERIL, a famous international medical project-construction corporation in Italy, and carried out the turn-key project. In 1998, Huaren imported its nucleus equipments for water making, solution making, bag making-filling and inspection from Europe; the introduction of double chamber bag production line fills the blank in China.
As the enlargement of market need, Huaren started the second stage construction on April 5th 2008, and passed the State GMP certificate on August 27th 2009. There are the most advanced production lines in the State, and full automated overhead warehouse in the new factory. Its going into production is a milestone in Huaren’s development. After finishing the second stage construction, we have capacity of around 100million bags. It strengthens our competitive strength on production cost and quality in the market.
Pharmaceuticals industry has respect to the national economy and the people's livelihood, should not have any product of inferior quality. Maintaining a high sense of responsibility to lives, the company insists the management philosophy of “Keep Healthy start from dribs and drabs”, and carries out quality control on departmental and overall process, insisting the faith of “Environment-Friendly，Healthy and Safety”. According to Country GMP and SFDA Standards of management, the company carried on omnibearing confirmation, management and control on personnel, equipments, instruments and techniques, environment and so on. Carrying on physical, chemistry and biology examination from raw materials to end production, it reaches the requirements of American FDA, European pharmacopoeia standard and national standards, leading in the state.
On research and development, in the new research and development centre, we have made significant progress and breakthrough in some Non-PVC I.V. solution programs with highly added value and competitive strength in the market, such as fat emulsions, amino acids, and dextran, parenteral nutrition double-chamber bags. Among these programs, the fat emulsions program has finished all study of pharmacy, and has reported to SFDA. Organ preservation and combination connection of Non-PVC I.V. solution bag have already declared the invention patent with proprietary intellectual property rights to the State.